Andy Slavitt, CMS team applauded for MACRA final rule rollout

Friday was a good day for CMS Acting Administrator Andy Slavitt on Twitter. His team transformed the way CMS communicates policy updates — and their work did not go unnoticed.

Advertisement

CMS is known for dropping dense policies late on a Friday afternoon, but with the final rule for the Medicare Access and CHIP Reauthorization Act, the agency released the rule early Friday, with a host of press releases, fact sheets and additional resources. The CMS team even created a modern, easy-to-understand website for physicians, explaining the rule in-depth.

The approach was met with approval. Mr. Slavitt has been following along with the praise on his Twitter feed today.

Thank you. It made all the difference. As you say, more to come. https://t.co/BlgIZgKrU3

— Andy Slavitt (@ASlavitt) October 14, 2016

Very good traffic today. https://t.co/LQlQqsGYkB

— Andy Slavitt (@ASlavitt) October 14, 2016

Thanks for the feedback. And thanks to @USDS who worked side-by-side w physicians designing this. https://t.co/QkcYWYizDv

— Andy Slavitt (@ASlavitt) October 14, 2016

 

More articles on finance:

Top 10 states ranked by percentage of births financed by Medicaid
19 recent hospital outlook and credit rating actions
Healthcare spending up 5.5% in August

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.